乳酸代谢相关基因在败血症的诊断和预后价值
Guitao Pan1, Guiming Huang2, Ruiming Deng2
1Department of Oral and Maxillofacial Surgery, Ganzhou People's Hospital, Ganzhou City, Jiangxi Province, China.
Clinics (Sao Paulo, Brazil)
|August 7, 2025
概括
这项研究确定了四种与乳酸代谢相关的基因 (LMRGs) 作为毒症的潜在诊断标志物. 这些基因,包括ARG1,也显示出预后价值,为败血症诊断和治疗提供了新的见解.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 败血症是一个重大的全球健康挑战,需要改进诊断和预后工具.
- 乳酸代谢相关基因 (LMRGs) 在细胞能量产生和免疫反应中起着至关重要的作用,这表明它们可能参与败血症的发病.
研究的目的:
- 从LMRGs中识别出新的败血症诊断和预后生物标志物.
- 探索这些基因与免疫细胞透和患者生存的关联.
主要方法:
- 使用诸如分子签名和基因卡等数据库对599个LMRG进行生物信息分析.
- 使用了差异表达分析,蛋白与蛋白相互作用 (PPI) 网络和权重基因共同表达网络分析 (WGCNA).
- 为基因选择和验证,进行了最小绝对收缩和选择运算器 (LASSO),接收器运行特征 (ROC) 和卡普兰-梅尔 (K-M) 分析.
主要成果:
- 他们发现了四种诊断基因 (APRT,ARG1,UMPS,LDHB),主要涉及能量代谢和免疫路径.
- 确定ARG1和患者年龄是败血症的独立预后因素.
- 在患者群体之间观察到基因表达,免疫细胞透和生存率的显著差异.
结论:
- 这些已识别的基因 (APRT,ARG1,UMPS,LDHB) 是潜在的新生物标志物,用于毒症的诊断和治疗.
- 对这些LMRG的进一步研究可能会为败血症患者改善临床管理策略.
相关概念视频
01:35Pedigree Analysis
Overview
01:30Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...